124 related articles for article (PubMed ID: 2194155)
1. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
Jeffery GM; Frampton CM; Legge HM; Hart DN
Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
[TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma.
Pudek MR; Chan KW; Rogers PC; Teasdale JM
Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate.
Oberg G; Hällgren R; Venge P
Br J Haematol; 1987 Jul; 66(3):315-22. PubMed ID: 3304392
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
Zhang HZ; Ye X; Sun ZG
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid beta-2-microglobulin: a reliable index of leukaemic infiltration of central nervous system.
Storti S; Pagano L; Marra R; Teofili L; Ricerca BM; Leone G; Bizzi B
Scand J Haematol; 1986 Oct; 37(4):301-5. PubMed ID: 3538368
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases.
Twijnstra A; van Zanten AP; Nooyen WJ; Hart AA; Ongerboer de Visser BW
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):387-91. PubMed ID: 3525181
[TBL] [Abstract][Full Text] [Related]
9. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin.
Koch TR; Lichtenfeld KM; Wiernik PH
Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578
[TBL] [Abstract][Full Text] [Related]
10. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
[TBL] [Abstract][Full Text] [Related]
12. Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia.
Asami T; Tanaka A; Gunji T; Sakai K; Asami K
Acta Paediatr Scand; 1987 Mar; 76(2):260-5. PubMed ID: 3296627
[TBL] [Abstract][Full Text] [Related]
13. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system relapse surveillance by serial beta 2-microglobulin measurements in childhood acute lymphoblastic leukemia.
Clausen N; Ibsen KK
Acta Paediatr Scand; 1984 Nov; 73(6):848-54. PubMed ID: 6395626
[TBL] [Abstract][Full Text] [Related]
15. Soluble L-selectin increases in the cerebrospinal fluid prior to meningeal involvement in children with acute lymphoblastic leukemia.
Dagdemir A; Ertem U; Duru F; Kirazli S
Leuk Lymphoma; 1998 Jan; 28(3-4):391-8. PubMed ID: 9517511
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
17. Unreliability of beta-2-microglobulin in early detection of central nervous system relapse in acute lymphoblastic leukemia.
Nagelkerke AF; van Kamp GJ; Veerman AJ; de Waal FC
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):659-63. PubMed ID: 3894031
[TBL] [Abstract][Full Text] [Related]
18. Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia.
Musto P; Tomasi P; Cascavilla N; Ladogana S; La Sala A; Melillo L; Nobile M; Castoldi G; Carotenuto M
Am J Hematol; 1988 Aug; 28(4):213-8. PubMed ID: 3046340
[TBL] [Abstract][Full Text] [Related]
19. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients.
Marra R; Pagano L; Storti S; Massaro A; Teofili L; Carbone G; Leone G
Scand J Clin Lab Invest; 1987 Dec; 47(8):765-9. PubMed ID: 3432998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
